mRNA Platform Market Research Report 2023 - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F
December 01, 2023 06:18 ET
|
Research and Markets
Dublin, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The "mRNA Platform Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ResearchAndMarkets.com's...
North America Digital Vaccine Markets, Competition, Forecast & Opportunities Report 2023-2028 Featuring Friendslearn, Klein Buendel, Evidation Health, Atos, and oVRcome
November 27, 2023 07:18 ET
|
Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "North America Digital Vaccine Market, Competition, Forecast & Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Inequitable Access Remains a Challenge in the HBV Vaccine Market Despite Increasing Healthcare Expenditure
November 10, 2023 08:38 ET
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Hepatitis B Virus (HBV) Vaccine Market (by End User, Composition, & Region): Insights and Forecast with Potential Impact of COVID-19...
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 09, 2023 16:05 ET
|
HilleVax, Inc.
BOSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...
Global Therapeutic Vaccines Market Analysis 2023-2028: Regulatory Complexities Slow Entry Into the ~$12 Billion-Projected Industry
November 06, 2023 07:48 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Therapeutic Vaccines Market (2023-2028) by Product, Disease Indication, Technology, End User, and Geography, Competitive Analysis, Impact of...
HilleVax to Present at Upcoming Investor Conferences
November 01, 2023 16:48 ET
|
HilleVax, Inc.
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Global Malaria Vaccine Market Set for Remarkable Growth in the Fight Against Malaria
October 31, 2023 08:08 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Malaria Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
Global Therapeutics Vaccine Markets, Trends, Opportunities, and Forecast, 2018-2022 & 20232028F
October 27, 2023 08:23 ET
|
Research and Markets
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The "Therapeutics Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Next-Generation RNA Therapeutics and Vaccines Surge: Promising Modalities and Clinical Trials Fueling Growth in the RNA Market
October 12, 2023 05:43 ET
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical...
Global Influenza Vaccine Market Research Report 2023: A $12.32 Billion Market by 2028 Driven by Increased Vaccine Awareness, Post COVID-19
October 05, 2023 09:43 ET
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Influenza Vaccine Market: Analysis by Valency, By Vaccine Type, By Technology, By Age Group, By Route Of Administration, By Distribution...